- Home
- KIDS vs CRMD Comparison
KIDS vs CRMD Comparison
Compare KIDS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- CRMD
- Stock Information
- Founded
- KIDS 2007
- CRMD 2006
- Country
- KIDS United States
- CRMD United States
- Employees
- KIDS N/A
- CRMD N/A
- Industry
- KIDS Medical/Dental Instruments
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- KIDS Health Care
- CRMD Health Care
- Exchange
- KIDS Nasdaq
- CRMD Nasdaq
- Market Cap
- KIDS 530.8M
- CRMD 973.3M
- IPO Year
- KIDS 2017
- CRMD 2010
- Fundamental
- Price
- KIDS $22.48
- CRMD $11.40
- Analyst Decision
- KIDS Buy
- CRMD Strong Buy
- Analyst Count
- KIDS 7
- CRMD 7
- Target Price
- KIDS $35.71
- CRMD $17.33
- AVG Volume (30 Days)
- KIDS 137.2K
- CRMD 2.5M
- Earning Date
- KIDS 08-04-2025
- CRMD 08-13-2025
- Dividend Yield
- KIDS N/A
- CRMD N/A
- EPS Growth
- KIDS N/A
- CRMD N/A
- EPS
- KIDS N/A
- CRMD 0.28
- Revenue
- KIDS $212,453,000.00
- CRMD $82,553,827.00
- Revenue This Year
- KIDS $19.23
- CRMD $238.38
- Revenue Next Year
- KIDS $17.14
- CRMD $53.52
- P/E Ratio
- KIDS N/A
- CRMD $41.86
- Revenue Growth
- KIDS 31.28
- CRMD N/A
- 52 Week Low
- KIDS $19.52
- CRMD $3.61
- 52 Week High
- KIDS $35.99
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- KIDS 61.04
- CRMD 39.52
- Support Level
- KIDS $21.00
- CRMD $12.14
- Resistance Level
- KIDS $21.83
- CRMD $17.43
- Average True Range (ATR)
- KIDS 0.74
- CRMD 0.69
- MACD
- KIDS 0.19
- CRMD -0.51
- Stochastic Oscillator
- KIDS 97.94
- CRMD 4.60
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.